Evidence map›Paper›PMID 33957127›Full record

ArticleThe Journal of biological chemistry

Opposing roles of E3 ligases TRIM23 and TRIM21 in regulation of ion channel ANO1 protein levels.

Xu Cao, Zijing Zhou, Ye Tian, Zhengzhao Liu, Kar On Cheng, Xibing Chen, Wenbao Hu, Yuk Ming Wong, Xiaofen Li, Hailin Zhang and 2 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Xu CaoDivision of Life Science, Hong Kong University of Science and Technology, Hong Kong, People's Republic of China.
Zijing ZhouDivision of Life Science, Hong Kong University of Science and Technology, Hong Kong, People's Republic of China.
Ye TianDivision of Life Science, Hong Kong University of Science and Technology, Hong Kong, People's Republic of China.
Zhengzhao LiuDivision of Life Science, Hong Kong University of Science and Technology, Hong Kong, People's Republic of China; State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China; Xiangya Hospital, Central South University, Changsha, China.
Kar On ChengDivision of Life Science, Hong Kong University of Science and Technology, Hong Kong, People's Republic of China.
Xibing ChenDivision of Life Science, Hong Kong University of Science and Technology, Hong Kong, People's Republic of China.
Wenbao HuDivision of Life Science, Hong Kong University of Science and Technology, Hong Kong, People's Republic of China.
Yuk Ming WongDivision of Life Science, Hong Kong University of Science and Technology, Hong Kong, People's Republic of China.
Xiaofen LiDivision of Life Science, Hong Kong University of Science and Technology, Hong Kong, People's Republic of China.
Hailin ZhangDepartment of Pharmacology, Hebei Medical University, Shijiazhuang, People's Republic of China.
Ronggui HuState Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China; Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China; School of Life Science, Hangzhou Institute for Advance Study, University of Chinese Academy of Sciences, Hangzhou, China.
Pingbo HuangDivision of Life Science, Hong Kong University of Science and Technology, Hong Kong, People's Republic of China; Department of Chemical and Biological Engineering, Hong Kong University of Science and Technology, Hong Kong, People's Republic of China; State Key Laboratory of Molecular Neuroscience, Hong Kong University of Science and Technology, Hong Kong, People's Republic of China; HKUST Shenzhen Research Institute, Hong Kong University of Science and Technology, Hong Kong, People's Republic of China; Hong Kong Branch of Guangdong Southern Marine Science and Engineering Laboratory (Guangzhou), Hong Kong University of Science and Technology, Hong Kong, People's Republic of China. Electronic address: bohuangp@ust.hk.
Hong Kong University of Science and Technology · HKCentral South University · CNHebei Medical University · CNTongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anoctamin-1 (ANO1) (TMEM16A) is a calcium-activated chloride channel that plays critical roles in diverse physiological processes, such as sensory transduction and epithelial secretion. ANO1 levels have been shown to be altered under physiological and pathological conditions, although the molecular mechanisms that control ANO1 protein levels remain unclear. The ubiquitin-proteasome system is known to regulate the levels of numerous ion channels, but little information is available regarding whether and how ubiquitination regulates levels of ANO1. Here, we showed that two E3 ligases, TRIM23 and TRIM21, physically interact with the C terminus of ANO1. In vitro and in vivo assays demonstrated that whereas TRIM23 ubiquitinated ANO1 leading to its stabilization, TRIM21 ubiquitinated ANO1 and induced its degradation. Notably, ANO1 regulation by TRIM23 and TRIM21 is involved in chemical-induced pain sensation, salivary secretion, and heart-rate control in mice, and TRIM23 also mediates ANO1 upregulation induced by epidermal growth factor treatment. Our results suggest that these two antagonistic E3 ligases act together to control ANO1 expression and function. Our findings reveal a previously unrecognized mechanism for regulating ANO1 protein levels and identify a potential molecular link between ANO1 regulation, epidermal growth factor, and other signaling pathways.

Indexed as

Anoctamin-1GTP-Binding ProteinsHEK293 CellsHumansNeoplasm ProteinsProtein StabilityProteolysisRibonucleoproteinsSS-A AntigenUbiquitinationANO1 protein, humanAnoctamin-1GTP-Binding ProteinsNeoplasm ProteinsRibonucleoproteinsSS-A AntigenTRIM23 protein, humanANO1EGFTMEM16ATRIM21TRIM23

Identifiers

PMID33957127
PMCPMC8191318
OpenAlexW3158447429

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.